Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Healthcare-associated bacterial infections in hospitalized cirrhotic patients: traditional vs second-line empirical antibiotic therapy
2012-000173-22Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of imipenem + cilastatin in bacterial disease and Cirrhosis (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Complications. Started Aug 2012; status: active.
02
Drugs
imipenem + cilastatin
03
Conditions
bacterial diseaseCirrhosis
Beyond the preview
Go deeper on 2012-000173-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000173-22.